Artificial intelligence (AI) has been revolutionizing much of early drug discovery, yet human clinical trials remain a bottleneck. Now some applications of the new technologies are bringing ...

NINGBO, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global healthcare ...

Determining the cancer diagnostic interval using administrative data in a cohort of patients with pancreatic ductal adenocarcinoma (PDAC). This is an ASCO Meeting Abstract from the 2021 ASCO Annual ...

NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Accenture (NYSE: ACN) announced it has made a strategic investment, through Accenture Ventures, in QuantHealth, an AI-powered clinical trial design ...

The role of micro-CT for intraoperative margin assessment of breast cancer. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text component.

QuantHealth helps pharma implement artificial intelligence for drug development using clinical trial simulation. Orr Inbar, its cofounder and CEO, discusses that — and the long-term effects of AI on ...

Simulation is important in health professions education and training. Teamwork, communication skills, crisis resource management, and core clinical skills can be integrated into simulated patient care ...